4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane, 95.0%, 100g

4-(3-Bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol, 95.0%, 1g

Ethyl 4-piperidineacetate hydrochloride, 95.0%, 10g

2-(4-Fluorophenyl)pyrrolidine>98.0%(GC)1g

(6-Chloro-5-nitro-4-trifluoromethyl-pyridin-2-yl)-dimethyl-amine, 95.0%, 5g

4-Ethylbenzene-1,3-diol, 95.0%, 1g

Benzo(b)thiophene-2-carbonyl chloride, 98.0%, 250mg

N,O-Bis(tert-butyldimethylsilyl)acetamide [tert-Butyldimethylsilylating Agent]>96.0%(GC)5g

(S)-Piperidin-3-ol, 97%, 1g

L(+)-tartaric acid, min. 99.5%, pa, ACS, ISO, 250 g, plastic packaging.

5-Methyl-2-(trifluoromethyl)benzyl bromide, 5g

[(4-Bromo-2-fluorophenyl)methyl]diethylamine, 97%, 1g

(Ethoxymethyl)benzene>98.0%(GC)5g